Literature DB >> 6289385

Bombesin production by human small cell carcinoma of the lung.

G D Sorenson, S R Bloom, M A Ghatei, S A Del Prete, C C Cate, O S Pettengill.   

Abstract

A series of continuous cell lines of human small cell carcinoma of the lung (SCCL) have been evaluated for the production of bombesin (BN). In early established cultures BN was detected in the medium of 9 out of 11 cell lines and in 6 out of 7 cell homogenates examined. Levels in the medium were frequently higher in cultures of later passages compared to earlier passages of the same line and low levels developed in the two previously negative cell lines. Plasma concentrations were greater than 80 pmol/l in 2 out of 27 (7%) randomly selected patients with SCCL. A culture (DMS 406) established from the tumor of a patient with the highest plasma level (1240 pmol/l) was the highest producer in vitro. The results indicate that BN, which has been demonstrated immunocytochemically to be present in normal bronchial mucosal cells, is frequently produced by SCCL in vitro but elevated plasma levels are infrequently found in patients with this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289385     DOI: 10.1016/0167-0115(82)90095-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  11 in total

1.  Protein kinase C-mediated negative-feedback inhibition of unstimulated and bombesin-stimulated polyphosphoinositide hydrolysis in Swiss-mouse 3T3 cells.

Authors:  K D Brown; D M Blakeley; M H Hamon; M S Laurie; A N Corps
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

2.  Immunocytochemical staining of cytocentrifuge prepared cultured cells: nonspecific staining and its elimination.

Authors:  E J Gosselin; J C Dennett; G D Sorenson; O S Pettengill; C C Cate
Journal:  Histochem J       Date:  1985-08

3.  Localisation of receptors using a dimeric ligand and electron immunocytochemistry.

Authors:  P M Lackie; F Cuttitta; J D Minna; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1985

Review 4.  Somatostatin and analogues in the treatment of cancer. A review.

Authors:  B M Evers; D Parekh; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

5.  Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.

Authors:  E D Ball; K E Nichols; O S Pettengill; G D Sorenson; M W Fanger
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Characterization of the high-affinity receptors on Swiss 3T3 cells which mediate the binding, internalization and degradation of the mitogenic peptide bombesin.

Authors:  K D Brown; M S Laurie; C J Littlewood; D M Blakeley; A N Corps
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

7.  Neuropeptides in neurological tumours.

Authors:  J M Allen; N R Hoyle; J C Yeats; M A Ghatei; D G Thomas; S R Bloom
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

8.  Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors.

Authors:  D G Bostwick; K A Roth; C J Evans; J D Barchas; K G Bensch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

Review 9.  Autocrine growth factors and solid tumor malignancy.

Authors:  J H Walsh; W E Karnes; F Cuttitta; A Walker
Journal:  West J Med       Date:  1991-08

10.  Plasma GRP-like immunoreactivity in healthy and diseased subjects.

Authors:  Y Haraguchi; A Sakamoto; T Yoshida; K Tanaka
Journal:  Gastroenterol Jpn       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.